Mycrodose Therapeutics successfully closes oversubscribed seven-figure financing round. Financing was funded by multiple high profile institutional investors, VCs, and Psychedelic Funds, including; The Conscious Fund, Negev Capital, Ambria Capital, K2 & Associates, Empath Ventures, Supernode, Receptor Fund, and many high profiles Silicon Valley Executives. Mycrodose Therapeutics is widely…


Previous articleAre Prodrugs the Next Wave of Psychedelic Drug Development?
Next articlePsychedelics: Past, Present, Future – Webinar